{"title":"五年内再次接受物质相关障碍治疗的预测因素。","authors":"Marie-Josée Fleury , Sharmin Sharker , Guy Grenier , Myriam Beaulieu , Christophe Huỳnh","doi":"10.1016/j.drugpo.2025.105016","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Treatment readmission is frequent among patients with substance-related disorders (SRDs). This study aimed to identify clinical, sociodemographic and service use predictors of readmission to SRD treatment within a 5-year period (2017–2022) following initial treatment episodes.</div></div><div><h3>Methods</h3><div>Data from 8277 patients showing at least one SRD treatment episode in specialized addiction treatment centers in 2013–2017 (Quebec, Canada) were merged with provincial health administrative databases (1996–2022). Readmission predictors were tested using Cox proportional hazards to measure patient characteristics, and SRD treatment over the previous 8 years (2009–2017). Logistic regression assessed other service use for the 12 previous months, as co-occurring disorders could influence readmission.</div></div><div><h3>Results</h3><div>Over the 5 years following their last SRD treatment, 36 % of patients were readmitted. Were more likely to be readmitted: men, individuals who were younger, unemployed, not living in rural areas, had chronic SRDs, alcohol-related disorders, common mental disorders, 5+ prior SRD care episodes, got residential treatment, showed high dropout rates, and those who waited <30 days to access treatment. Readmission was likelier in patients who had access to psychiatrists and psychosocial services, had high continuity of physician care, and used more acute care – especially emergency departments.</div></div><div><h3>Conclusion</h3><div>Patients with more social and health issues and high prior and diversified service use showed higher risk of readmission. This suggests that care could be improved significantly to reduce readmission, especially through better detection and need assessment of patients with multiple prior SRD treatment episodes, dropouts and acute care use, and by increasing long-term follow-up care.</div></div>","PeriodicalId":48364,"journal":{"name":"International Journal of Drug Policy","volume":"145 ","pages":"Article 105016"},"PeriodicalIF":4.4000,"publicationDate":"2025-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Predictors of readmission to substance-related disorder treatment over a five-year period\",\"authors\":\"Marie-Josée Fleury , Sharmin Sharker , Guy Grenier , Myriam Beaulieu , Christophe Huỳnh\",\"doi\":\"10.1016/j.drugpo.2025.105016\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>Treatment readmission is frequent among patients with substance-related disorders (SRDs). This study aimed to identify clinical, sociodemographic and service use predictors of readmission to SRD treatment within a 5-year period (2017–2022) following initial treatment episodes.</div></div><div><h3>Methods</h3><div>Data from 8277 patients showing at least one SRD treatment episode in specialized addiction treatment centers in 2013–2017 (Quebec, Canada) were merged with provincial health administrative databases (1996–2022). Readmission predictors were tested using Cox proportional hazards to measure patient characteristics, and SRD treatment over the previous 8 years (2009–2017). Logistic regression assessed other service use for the 12 previous months, as co-occurring disorders could influence readmission.</div></div><div><h3>Results</h3><div>Over the 5 years following their last SRD treatment, 36 % of patients were readmitted. Were more likely to be readmitted: men, individuals who were younger, unemployed, not living in rural areas, had chronic SRDs, alcohol-related disorders, common mental disorders, 5+ prior SRD care episodes, got residential treatment, showed high dropout rates, and those who waited <30 days to access treatment. Readmission was likelier in patients who had access to psychiatrists and psychosocial services, had high continuity of physician care, and used more acute care – especially emergency departments.</div></div><div><h3>Conclusion</h3><div>Patients with more social and health issues and high prior and diversified service use showed higher risk of readmission. This suggests that care could be improved significantly to reduce readmission, especially through better detection and need assessment of patients with multiple prior SRD treatment episodes, dropouts and acute care use, and by increasing long-term follow-up care.</div></div>\",\"PeriodicalId\":48364,\"journal\":{\"name\":\"International Journal of Drug Policy\",\"volume\":\"145 \",\"pages\":\"Article 105016\"},\"PeriodicalIF\":4.4000,\"publicationDate\":\"2025-09-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Drug Policy\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0955395925003123\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"SUBSTANCE ABUSE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Drug Policy","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0955395925003123","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"SUBSTANCE ABUSE","Score":null,"Total":0}
Predictors of readmission to substance-related disorder treatment over a five-year period
Background
Treatment readmission is frequent among patients with substance-related disorders (SRDs). This study aimed to identify clinical, sociodemographic and service use predictors of readmission to SRD treatment within a 5-year period (2017–2022) following initial treatment episodes.
Methods
Data from 8277 patients showing at least one SRD treatment episode in specialized addiction treatment centers in 2013–2017 (Quebec, Canada) were merged with provincial health administrative databases (1996–2022). Readmission predictors were tested using Cox proportional hazards to measure patient characteristics, and SRD treatment over the previous 8 years (2009–2017). Logistic regression assessed other service use for the 12 previous months, as co-occurring disorders could influence readmission.
Results
Over the 5 years following their last SRD treatment, 36 % of patients were readmitted. Were more likely to be readmitted: men, individuals who were younger, unemployed, not living in rural areas, had chronic SRDs, alcohol-related disorders, common mental disorders, 5+ prior SRD care episodes, got residential treatment, showed high dropout rates, and those who waited <30 days to access treatment. Readmission was likelier in patients who had access to psychiatrists and psychosocial services, had high continuity of physician care, and used more acute care – especially emergency departments.
Conclusion
Patients with more social and health issues and high prior and diversified service use showed higher risk of readmission. This suggests that care could be improved significantly to reduce readmission, especially through better detection and need assessment of patients with multiple prior SRD treatment episodes, dropouts and acute care use, and by increasing long-term follow-up care.
期刊介绍:
The International Journal of Drug Policy provides a forum for the dissemination of current research, reviews, debate, and critical analysis on drug use and drug policy in a global context. It seeks to publish material on the social, political, legal, and health contexts of psychoactive substance use, both licit and illicit. The journal is particularly concerned to explore the effects of drug policy and practice on drug-using behaviour and its health and social consequences. It is the policy of the journal to represent a wide range of material on drug-related matters from around the world.